0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Anti-HMGB1 Antibody Market Research Report 2026
Published Date: 2026-03-20
|
Report Code: QYRE-Auto-17J17714
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Anti HMGB1 Antibody Market Research Report 2024
BUY CHAPTERS

Global Anti-HMGB1 Antibody Market Research Report 2026

Code: QYRE-Auto-17J17714
Report
2026-03-20
Pages:126
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Anti-HMGB1 Antibody Market

The global Anti-HMGB1 Antibody market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Anti-HMGB1 Antibody competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Anti-HMGB1 antibody is an antibody that targets and binds to the HMGB1 protein, a nuclear protein with roles in inflammation, DNA repair, and gene regulation, commonly used in research and diagnostic tests to investigate HMGB1 expression and its involvement in various cellular processes.
The North American market for Anti-HMGB1 Antibody is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The Asia-Pacific market for Anti-HMGB1 Antibody is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
Major global manufacturers of Anti-HMGB1 Antibody include Genetex, Thermo Fisher Scientific, Abcam, BioLegend, Sino Biological, Atlas Antibodies, Merck, Arigo Biolaboratories, Chondrex, BosterBio, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.
This report delivers a comprehensive overview of the global Anti-HMGB1 Antibody market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Anti-HMGB1 Antibody. The Anti-HMGB1 Antibody market size, estimates, and forecasts are provided in terms of sales volume (kg) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Anti-HMGB1 Antibody market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Anti-HMGB1 Antibody manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of Anti-HMGB1 Antibody Market Report

Report Metric Details
Report Name Anti-HMGB1 Antibody Market
Segment by Type
  • Rabbit Anti-HMGB1 Antibody
  • Mouse Anti-HMGB1 Antibody
by Application
  • ELISA
  • Immunofluorescence
  • Western Blot
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Genetex, Thermo Fisher Scientific, Abcam, BioLegend, Sino Biological, Atlas Antibodies, Merck, Arigo Biolaboratories, Chondrex, BosterBio, St John's Laboratory, Leadgene Biomedical, Raybiotech
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Provides a detailed analysis of the competitive landscape for Anti-HMGB1 Antibody manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
  • Chapter 3: Examines Anti-HMGB1 Antibody sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
  • Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
  • Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
  • Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
  • Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
  • Chapter 9: Summarizes the key findings and conclusions of the report.

FAQ for this report

Who are the main players in the Anti-HMGB1 Antibody Market report?

Ans: The main players in the Anti-HMGB1 Antibody Market are Genetex, Thermo Fisher Scientific, Abcam, BioLegend, Sino Biological, Atlas Antibodies, Merck, Arigo Biolaboratories, Chondrex, BosterBio, St John's Laboratory, Leadgene Biomedical, Raybiotech

What are the Application segmentation covered in the Anti-HMGB1 Antibody Market report?

Ans: The Applications covered in the Anti-HMGB1 Antibody Market report are ELISA, Immunofluorescence, Western Blot, Others

What are the Type segmentation covered in the Anti-HMGB1 Antibody Market report?

Ans: The Types covered in the Anti-HMGB1 Antibody Market report are Rabbit Anti-HMGB1 Antibody, Mouse Anti-HMGB1 Antibody

1 Anti-HMGB1 Antibody Market Overview
1.1 Product Definition
1.2 Anti-HMGB1 Antibody by Type
1.2.1 Global Anti-HMGB1 Antibody Market Value by Type: 2025 vs 2032
1.2.2 Rabbit Anti-HMGB1 Antibody
1.2.3 Mouse Anti-HMGB1 Antibody
1.3 Anti-HMGB1 Antibody by Application
1.3.1 Global Anti-HMGB1 Antibody Market Value by Application: 2025 vs 2032
1.3.2 ELISA
1.3.3 Immunofluorescence
1.3.4 Western Blot
1.3.5 Others
1.4 Global Anti-HMGB1 Antibody Market Size Estimates and Forecasts
1.4.1 Global Anti-HMGB1 Antibody Revenue 2021–2032
1.4.2 Global Anti-HMGB1 Antibody Sales 2021–2032
1.4.3 Global Anti-HMGB1 Antibody Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Anti-HMGB1 Antibody Market Competition by Manufacturers
2.1 Global Anti-HMGB1 Antibody Sales Market Share by Manufacturers (2021–2026)
2.2 Global Anti-HMGB1 Antibody Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Anti-HMGB1 Antibody Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Anti-HMGB1 Antibody, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Anti-HMGB1 Antibody, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Anti-HMGB1 Antibody, Product Types and Applications
2.7 Global Key Manufacturers of Anti-HMGB1 Antibody, Date of Entry into the Industry
2.8 Global Anti-HMGB1 Antibody Market Competitive Situation and Trends
2.8.1 Global Anti-HMGB1 Antibody Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Anti-HMGB1 Antibody Players Market Share by Revenue
2.8.3 Global Anti-HMGB1 Antibody Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Anti-HMGB1 Antibody Market Scenario by Region
3.1 Global Anti-HMGB1 Antibody Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Anti-HMGB1 Antibody Sales by Region: 2021–2032
3.2.1 Global Anti-HMGB1 Antibody Sales by Region: 2021–2026
3.2.2 Global Anti-HMGB1 Antibody Sales by Region: 2027–2032
3.3 Global Anti-HMGB1 Antibody Revenue by Region: 2021–2032
3.3.1 Global Anti-HMGB1 Antibody Revenue by Region: 2021–2026
3.3.2 Global Anti-HMGB1 Antibody Revenue by Region: 2027–2032
3.4 North America Anti-HMGB1 Antibody Market Facts & Figures by Country
3.4.1 North America Anti-HMGB1 Antibody Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Anti-HMGB1 Antibody Sales by Country (2021–2032)
3.4.3 North America Anti-HMGB1 Antibody Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Anti-HMGB1 Antibody Market Facts & Figures by Country
3.5.1 Europe Anti-HMGB1 Antibody Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Anti-HMGB1 Antibody Sales by Country (2021–2032)
3.5.3 Europe Anti-HMGB1 Antibody Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Anti-HMGB1 Antibody Market Facts & Figures by Region
3.6.1 Asia Pacific Anti-HMGB1 Antibody Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Anti-HMGB1 Antibody Sales by Region (2021–2032)
3.6.3 Asia Pacific Anti-HMGB1 Antibody Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Anti-HMGB1 Antibody Market Facts & Figures by Country
3.7.1 Latin America Anti-HMGB1 Antibody Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Anti-HMGB1 Antibody Sales by Country (2021–2032)
3.7.3 Latin America Anti-HMGB1 Antibody Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Anti-HMGB1 Antibody Market Facts & Figures by Country
3.8.1 Middle East and Africa Anti-HMGB1 Antibody Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Anti-HMGB1 Antibody Sales by Country (2021–2032)
3.8.3 Middle East and Africa Anti-HMGB1 Antibody Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Anti-HMGB1 Antibody Sales by Type (2021–2032)
4.1.1 Global Anti-HMGB1 Antibody Sales by Type (2021–2026)
4.1.2 Global Anti-HMGB1 Antibody Sales by Type (2027–2032)
4.1.3 Global Anti-HMGB1 Antibody Sales Market Share by Type (2021–2032)
4.2 Global Anti-HMGB1 Antibody Revenue by Type (2021–2032)
4.2.1 Global Anti-HMGB1 Antibody Revenue by Type (2021–2026)
4.2.2 Global Anti-HMGB1 Antibody Revenue by Type (2027–2032)
4.2.3 Global Anti-HMGB1 Antibody Revenue Market Share by Type (2021–2032)
4.3 Global Anti-HMGB1 Antibody Price by Type (2021–2032)
5 Segment by Application
5.1 Global Anti-HMGB1 Antibody Sales by Application (2021–2032)
5.1.1 Global Anti-HMGB1 Antibody Sales by Application (2021–2026)
5.1.2 Global Anti-HMGB1 Antibody Sales by Application (2027–2032)
5.1.3 Global Anti-HMGB1 Antibody Sales Market Share by Application (2021–2032)
5.2 Global Anti-HMGB1 Antibody Revenue by Application (2021–2032)
5.2.1 Global Anti-HMGB1 Antibody Revenue by Application (2021–2026)
5.2.2 Global Anti-HMGB1 Antibody Revenue by Application (2027–2032)
5.2.3 Global Anti-HMGB1 Antibody Revenue Market Share by Application (2021–2032)
5.3 Global Anti-HMGB1 Antibody Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Genetex
6.1.1 Genetex Company Information
6.1.2 Genetex Description and Business Overview
6.1.3 Genetex Anti-HMGB1 Antibody Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Genetex Anti-HMGB1 Antibody Product Portfolio
6.1.5 Genetex Recent Developments/Updates
6.2 Thermo Fisher Scientific
6.2.1 Thermo Fisher Scientific Company Information
6.2.2 Thermo Fisher Scientific Description and Business Overview
6.2.3 Thermo Fisher Scientific Anti-HMGB1 Antibody Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Thermo Fisher Scientific Anti-HMGB1 Antibody Product Portfolio
6.2.5 Thermo Fisher Scientific Recent Developments/Updates
6.3 Abcam
6.3.1 Abcam Company Information
6.3.2 Abcam Description and Business Overview
6.3.3 Abcam Anti-HMGB1 Antibody Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Abcam Anti-HMGB1 Antibody Product Portfolio
6.3.5 Abcam Recent Developments/Updates
6.4 BioLegend
6.4.1 BioLegend Company Information
6.4.2 BioLegend Description and Business Overview
6.4.3 BioLegend Anti-HMGB1 Antibody Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 BioLegend Anti-HMGB1 Antibody Product Portfolio
6.4.5 BioLegend Recent Developments/Updates
6.5 Sino Biological
6.5.1 Sino Biological Company Information
6.5.2 Sino Biological Description and Business Overview
6.5.3 Sino Biological Anti-HMGB1 Antibody Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Sino Biological Anti-HMGB1 Antibody Product Portfolio
6.5.5 Sino Biological Recent Developments/Updates
6.6 Atlas Antibodies
6.6.1 Atlas Antibodies Company Information
6.6.2 Atlas Antibodies Description and Business Overview
6.6.3 Atlas Antibodies Anti-HMGB1 Antibody Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Atlas Antibodies Anti-HMGB1 Antibody Product Portfolio
6.6.5 Atlas Antibodies Recent Developments/Updates
6.7 Merck
6.7.1 Merck Company Information
6.7.2 Merck Description and Business Overview
6.7.3 Merck Anti-HMGB1 Antibody Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Merck Anti-HMGB1 Antibody Product Portfolio
6.7.5 Merck Recent Developments/Updates
6.8 Arigo Biolaboratories
6.8.1 Arigo Biolaboratories Company Information
6.8.2 Arigo Biolaboratories Description and Business Overview
6.8.3 Arigo Biolaboratories Anti-HMGB1 Antibody Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Arigo Biolaboratories Anti-HMGB1 Antibody Product Portfolio
6.8.5 Arigo Biolaboratories Recent Developments/Updates
6.9 Chondrex
6.9.1 Chondrex Company Information
6.9.2 Chondrex Description and Business Overview
6.9.3 Chondrex Anti-HMGB1 Antibody Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Chondrex Anti-HMGB1 Antibody Product Portfolio
6.9.5 Chondrex Recent Developments/Updates
6.10 BosterBio
6.10.1 BosterBio Company Information
6.10.2 BosterBio Description and Business Overview
6.10.3 BosterBio Anti-HMGB1 Antibody Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 BosterBio Anti-HMGB1 Antibody Product Portfolio
6.10.5 BosterBio Recent Developments/Updates
6.11 St John's Laboratory
6.11.1 St John's Laboratory Company Information
6.11.2 St John's Laboratory Description and Business Overview
6.11.3 St John's Laboratory Anti-HMGB1 Antibody Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 St John's Laboratory Anti-HMGB1 Antibody Product Portfolio
6.11.5 St John's Laboratory Recent Developments/Updates
6.12 Leadgene Biomedical
6.12.1 Leadgene Biomedical Company Information
6.12.2 Leadgene Biomedical Description and Business Overview
6.12.3 Leadgene Biomedical Anti-HMGB1 Antibody Sales, Revenue, and Gross Margin (2021–2026)
6.12.4 Leadgene Biomedical Anti-HMGB1 Antibody Product Portfolio
6.12.5 Leadgene Biomedical Recent Developments/Updates
6.13 Raybiotech
6.13.1 Raybiotech Company Information
6.13.2 Raybiotech Description and Business Overview
6.13.3 Raybiotech Anti-HMGB1 Antibody Sales, Revenue, and Gross Margin (2021–2026)
6.13.4 Raybiotech Anti-HMGB1 Antibody Product Portfolio
6.13.5 Raybiotech Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Anti-HMGB1 Antibody Industry Chain Analysis
7.2 Anti-HMGB1 Antibody Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Anti-HMGB1 Antibody Production Mode & Process Analysis
7.4 Anti-HMGB1 Antibody Sales and Marketing
7.4.1 Anti-HMGB1 Antibody Sales Channels
7.4.2 Anti-HMGB1 Antibody Distributors
7.5 Anti-HMGB1 Antibody Customer Analysis
8 Anti-HMGB1 Antibody Market Dynamics
8.1 Anti-HMGB1 Antibody Industry Trends
8.2 Anti-HMGB1 Antibody Market Drivers
8.3 Anti-HMGB1 Antibody Market Challenges
8.4 Anti-HMGB1 Antibody Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Anti-HMGB1 Antibody Market Value by Type (US$ Million), 2025 vs 2032
 Table 2. Global Anti-HMGB1 Antibody Market Value by Application (US$ Million), 2025 vs 2032
 Table 3. Global Anti-HMGB1 Antibody Market Competitive Situation by Manufacturers in 2025
 Table 4. Global Anti-HMGB1 Antibody Sales (kg) of Key Manufacturers (2021–2026)
 Table 5. Global Anti-HMGB1 Antibody Sales Market Share by Manufacturers (2021–2026)
 Table 6. Global Anti-HMGB1 Antibody Revenue (US$ Million) by Manufacturers (2021–2026)
 Table 7. Global Anti-HMGB1 Antibody Revenue Share by Manufacturers (2021–2026)
 Table 8. Global Market Anti-HMGB1 Antibody Average Price (US$/g) of Key Manufacturers (2021–2026)
 Table 9. Global Key Players of Anti-HMGB1 Antibody, Industry Ranking, 2023 vs 2024 vs 2025
 Table 10. Global Key Manufacturers of Anti-HMGB1 Antibody, Manufacturing Sites and Headquarters
 Table 11. Global Key Manufacturers of Anti-HMGB1 Antibody, Product Types and Applications
 Table 12. Global Key Manufacturers of Anti-HMGB1 Antibody, Date of Entry into the Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Anti-HMGB1 Antibody Companies by Tier (Tier 1, Tier 2, Tier 3), based on Anti-HMGB1 Antibody Revenue, 2025
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Anti-HMGB1 Antibody Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 17. Global Anti-HMGB1 Antibody Sales by Region (kg), 2021–2026
 Table 18. Global Anti-HMGB1 Antibody Sales Market Share by Region (2021–2026)
 Table 19. Global Anti-HMGB1 Antibody Sales by Region (kg), 2027–2032
 Table 20. Global Anti-HMGB1 Antibody Sales Market Share by Region (2027–2032)
 Table 21. Global Anti-HMGB1 Antibody Revenue by Region (US$ Million), 2021–2026
 Table 22. Global Anti-HMGB1 Antibody Revenue Market Share by Region (2021–2026)
 Table 23. Global Anti-HMGB1 Antibody Revenue by Region (US$ Million), 2027–2032
 Table 24. Global Anti-HMGB1 Antibody Revenue Market Share by Region (2027–2032)
 Table 25. North America Anti-HMGB1 Antibody Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 26. North America Anti-HMGB1 Antibody Sales by Country (kg), 2021–2026
 Table 27. North America Anti-HMGB1 Antibody Sales by Country (kg), 2027–2032
 Table 28. North America Anti-HMGB1 Antibody Revenue by Country (US$ Million), 2021–2026
 Table 29. North America Anti-HMGB1 Antibody Revenue by Country (US$ Million), 2027–2032
 Table 30. Europe Anti-HMGB1 Antibody Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 31. Europe Anti-HMGB1 Antibody Sales by Country (kg), 2021–2026
 Table 32. Europe Anti-HMGB1 Antibody Sales by Country (kg), 2027–2032
 Table 33. Europe Anti-HMGB1 Antibody Revenue by Country (US$ Million), 2021–2026
 Table 34. Europe Anti-HMGB1 Antibody Revenue by Country (US$ Million), 2027–2032
 Table 35. Asia Pacific Anti-HMGB1 Antibody Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
 Table 36. Asia Pacific Anti-HMGB1 Antibody Sales by Region (kg), 2021–2026
 Table 37. Asia Pacific Anti-HMGB1 Antibody Sales by Region (kg), 2027–2032
 Table 38. Asia Pacific Anti-HMGB1 Antibody Revenue by Region (US$ Million), 2021–2026
 Table 39. Asia Pacific Anti-HMGB1 Antibody Revenue by Region (US$ Million), 2027–2032
 Table 40. Latin America Anti-HMGB1 Antibody Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 41. Latin America Anti-HMGB1 Antibody Sales by Country (kg), 2021–2026
 Table 42. Latin America Anti-HMGB1 Antibody Sales by Country (kg), 2027–2032
 Table 43. Latin America Anti-HMGB1 Antibody Revenue by Country (US$ Million), 2021–2026
 Table 44. Latin America Anti-HMGB1 Antibody Revenue by Country (US$ Million), 2027–2032
 Table 45. Middle East and Africa Anti-HMGB1 Antibody Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 46. Middle East and Africa Anti-HMGB1 Antibody Sales by Country (kg), 2021–2026
 Table 47. Middle East and Africa Anti-HMGB1 Antibody Sales by Country (kg), 2027–2032
 Table 48. Middle East and Africa Anti-HMGB1 Antibody Revenue by Country (US$ Million), 2021–2026
 Table 49. Middle East and Africa Anti-HMGB1 Antibody Revenue by Country (US$ Million), 2027–2032
 Table 50. Global Anti-HMGB1 Antibody Sales (kg) by Type (2021–2026)
 Table 51. Global Anti-HMGB1 Antibody Sales (kg) by Type (2027–2032)
 Table 52. Global Anti-HMGB1 Antibody Sales Market Share by Type (2021–2026)
 Table 53. Global Anti-HMGB1 Antibody Sales Market Share by Type (2027–2032)
 Table 54. Global Anti-HMGB1 Antibody Revenue (US$ Million) by Type (2021–2026)
 Table 55. Global Anti-HMGB1 Antibody Revenue (US$ Million) by Type (2027–2032)
 Table 56. Global Anti-HMGB1 Antibody Revenue Market Share by Type (2021–2026)
 Table 57. Global Anti-HMGB1 Antibody Revenue Market Share by Type (2027–2032)
 Table 58. Global Anti-HMGB1 Antibody Price (US$/g) by Type (2021–2026)
 Table 59. Global Anti-HMGB1 Antibody Price (US$/g) by Type (2027–2032)
 Table 60. Global Anti-HMGB1 Antibody Sales (kg) by Application (2021–2026)
 Table 61. Global Anti-HMGB1 Antibody Sales (kg) by Application (2027–2032)
 Table 62. Global Anti-HMGB1 Antibody Sales Market Share by Application (2021–2026)
 Table 63. Global Anti-HMGB1 Antibody Sales Market Share by Application (2027–2032)
 Table 64. Global Anti-HMGB1 Antibody Revenue (US$ Million) by Application (2021–2026)
 Table 65. Global Anti-HMGB1 Antibody Revenue (US$ Million) by Application (2027–2032)
 Table 66. Global Anti-HMGB1 Antibody Revenue Market Share by Application (2021–2026)
 Table 67. Global Anti-HMGB1 Antibody Revenue Market Share by Application (2027–2032)
 Table 68. Global Anti-HMGB1 Antibody Price (US$/g) by Application (2021–2026)
 Table 69. Global Anti-HMGB1 Antibody Price (US$/g) by Application (2027–2032)
 Table 70. Genetex Company Information
 Table 71. Genetex Description and Business Overview
 Table 72. Genetex Anti-HMGB1 Antibody Sales (kg), Revenue (US$ Million), Price (US$/g), and Gross Margin (2021–2026)
 Table 73. Genetex Anti-HMGB1 Antibody Product
 Table 74. Genetex Recent Developments/Updates
 Table 75. Thermo Fisher Scientific Company Information
 Table 76. Thermo Fisher Scientific Description and Business Overview
 Table 77. Thermo Fisher Scientific Anti-HMGB1 Antibody Sales (kg), Revenue (US$ Million), Price (US$/g), and Gross Margin (2021–2026)
 Table 78. Thermo Fisher Scientific Anti-HMGB1 Antibody Product
 Table 79. Thermo Fisher Scientific Recent Developments/Updates
 Table 80. Abcam Company Information
 Table 81. Abcam Description and Business Overview
 Table 82. Abcam Anti-HMGB1 Antibody Sales (kg), Revenue (US$ Million), Price (US$/g), and Gross Margin (2021–2026)
 Table 83. Abcam Anti-HMGB1 Antibody Product
 Table 84. Abcam Recent Developments/Updates
 Table 85. BioLegend Company Information
 Table 86. BioLegend Description and Business Overview
 Table 87. BioLegend Anti-HMGB1 Antibody Sales (kg), Revenue (US$ Million), Price (US$/g), and Gross Margin (2021–2026)
 Table 88. BioLegend Anti-HMGB1 Antibody Product
 Table 89. BioLegend Recent Developments/Updates
 Table 90. Sino Biological Company Information
 Table 91. Sino Biological Description and Business Overview
 Table 92. Sino Biological Anti-HMGB1 Antibody Sales (kg), Revenue (US$ Million), Price (US$/g), and Gross Margin (2021–2026)
 Table 93. Sino Biological Anti-HMGB1 Antibody Product
 Table 94. Sino Biological Recent Developments/Updates
 Table 95. Atlas Antibodies Company Information
 Table 96. Atlas Antibodies Description and Business Overview
 Table 97. Atlas Antibodies Anti-HMGB1 Antibody Sales (kg), Revenue (US$ Million), Price (US$/g), and Gross Margin (2021–2026)
 Table 98. Atlas Antibodies Anti-HMGB1 Antibody Product
 Table 99. Atlas Antibodies Recent Developments/Updates
 Table 100. Merck Company Information
 Table 101. Merck Description and Business Overview
 Table 102. Merck Anti-HMGB1 Antibody Sales (kg), Revenue (US$ Million), Price (US$/g), and Gross Margin (2021–2026)
 Table 103. Merck Anti-HMGB1 Antibody Product
 Table 104. Merck Recent Developments/Updates
 Table 105. Arigo Biolaboratories Company Information
 Table 106. Arigo Biolaboratories Description and Business Overview
 Table 107. Arigo Biolaboratories Anti-HMGB1 Antibody Sales (kg), Revenue (US$ Million), Price (US$/g), and Gross Margin (2021–2026)
 Table 108. Arigo Biolaboratories Anti-HMGB1 Antibody Product
 Table 109. Arigo Biolaboratories Recent Developments/Updates
 Table 110. Chondrex Company Information
 Table 111. Chondrex Description and Business Overview
 Table 112. Chondrex Anti-HMGB1 Antibody Sales (kg), Revenue (US$ Million), Price (US$/g), and Gross Margin (2021–2026)
 Table 113. Chondrex Anti-HMGB1 Antibody Product
 Table 114. Chondrex Recent Developments/Updates
 Table 115. BosterBio Company Information
 Table 116. BosterBio Description and Business Overview
 Table 117. BosterBio Anti-HMGB1 Antibody Sales (kg), Revenue (US$ Million), Price (US$/g), and Gross Margin (2021–2026)
 Table 118. BosterBio Anti-HMGB1 Antibody Product
 Table 119. BosterBio Recent Developments/Updates
 Table 120. St John's Laboratory Company Information
 Table 121. St John's Laboratory Description and Business Overview
 Table 122. St John's Laboratory Anti-HMGB1 Antibody Sales (kg), Revenue (US$ Million), Price (US$/g), and Gross Margin (2021–2026)
 Table 123. St John's Laboratory Anti-HMGB1 Antibody Product
 Table 124. St John's Laboratory Recent Developments/Updates
 Table 125. Leadgene Biomedical Company Information
 Table 126. Leadgene Biomedical Description and Business Overview
 Table 127. Leadgene Biomedical Anti-HMGB1 Antibody Sales (kg), Revenue (US$ Million), Price (US$/g), and Gross Margin (2021–2026)
 Table 128. Leadgene Biomedical Anti-HMGB1 Antibody Product
 Table 129. Leadgene Biomedical Recent Developments/Updates
 Table 130. Raybiotech Company Information
 Table 131. Raybiotech Description and Business Overview
 Table 132. Raybiotech Anti-HMGB1 Antibody Sales (kg), Revenue (US$ Million), Price (US$/g), and Gross Margin (2021–2026)
 Table 133. Raybiotech Anti-HMGB1 Antibody Product
 Table 134. Raybiotech Recent Developments/Updates
 Table 135. Key Raw Materials Lists
 Table 136. Raw Materials Key Suppliers Lists
 Table 137. Anti-HMGB1 Antibody Distributors List
 Table 138. Anti-HMGB1 Antibody Customers List
 Table 139. Anti-HMGB1 Antibody Market Trends
 Table 140. Anti-HMGB1 Antibody Market Drivers
 Table 141. Anti-HMGB1 Antibody Market Challenges
 Table 142. Anti-HMGB1 Antibody Market Restraints
 Table 143. Research Programs/Design for This Report
 Table 144. Key Data Information from Secondary Sources
 Table 145. Key Data Information from Primary Sources
 Table 146. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Anti-HMGB1 Antibody
 Figure 2. Global Anti-HMGB1 Antibody Market Value by Type (US$ Million), 2021–2032
 Figure 3. Global Anti-HMGB1 Antibody Market Share by Type: 2025 & 2032
 Figure 4. Rabbit Anti-HMGB1 Antibody Product Picture
 Figure 5. Mouse Anti-HMGB1 Antibody Product Picture
 Figure 6. Global Anti-HMGB1 Antibody Market Value by Application (US$ Million), 2021–2032
 Figure 7. Global Anti-HMGB1 Antibody Market Share by Application: 2025 & 2032
 Figure 8. ELISA
 Figure 9. Immunofluorescence
 Figure 10. Western Blot
 Figure 11. Others
 Figure 12. Global Anti-HMGB1 Antibody Revenue, (US$ Million), 2021 vs 2025 vs 2032
 Figure 13. Global Anti-HMGB1 Antibody Market Size (US$ Million), 2021–2032
 Figure 14. Global Anti-HMGB1 Antibody Sales (kg), 2021–2032
 Figure 15. Global Anti-HMGB1 Antibody Average Price (US$/g), 2021–2032
 Figure 16. Anti-HMGB1 Antibody Report Years Considered
 Figure 17. Anti-HMGB1 Antibody Sales Share by Manufacturers in 2025
 Figure 18. Global Anti-HMGB1 Antibody Revenue Share by Manufacturers in 2025
 Figure 19. Top 5 and Top 10 Global Anti-HMGB1 Antibody Players: Market Share by Revenue in Anti-HMGB1 Antibody in 2025
 Figure 20. Anti-HMGB1 Antibody Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
 Figure 21. Global Anti-HMGB1 Antibody Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Figure 22. North America Anti-HMGB1 Antibody Sales Market Share by Country (2021–2032)
 Figure 23. North America Anti-HMGB1 Antibody Revenue Market Share by Country (2021–2032)
 Figure 24. United States Anti-HMGB1 Antibody Revenue Growth Rate (US$ Million), 2021–2032
 Figure 25. Canada Anti-HMGB1 Antibody Revenue Growth Rate (US$ Million), 2021–2032
 Figure 26. Europe Anti-HMGB1 Antibody Sales Market Share by Country (2021–2032)
 Figure 27. Europe Anti-HMGB1 Antibody Revenue Market Share by Country (2021–2032)
 Figure 28. Germany Anti-HMGB1 Antibody Revenue Growth Rate (US$ Million), 2021–2032
 Figure 29. France Anti-HMGB1 Antibody Revenue Growth Rate (US$ Million), 2021–2032
 Figure 30. U.K. Anti-HMGB1 Antibody Revenue Growth Rate (US$ Million), 2021–2032
 Figure 31. Italy Anti-HMGB1 Antibody Revenue Growth Rate (US$ Million), 2021–2032
 Figure 32. Russia Anti-HMGB1 Antibody Revenue Growth Rate (US$ Million), 2021–2032
 Figure 33. Asia Pacific Anti-HMGB1 Antibody Sales Market Share by Region (2021–2032)
 Figure 34. Asia Pacific Anti-HMGB1 Antibody Revenue Market Share by Region (2021–2032)
 Figure 35. China Anti-HMGB1 Antibody Revenue Growth Rate (US$ Million), 2021–2032
 Figure 36. Japan Anti-HMGB1 Antibody Revenue Growth Rate (US$ Million), 2021–2032
 Figure 37. South Korea Anti-HMGB1 Antibody Revenue Growth Rate (US$ Million), 2021–2032
 Figure 38. India Anti-HMGB1 Antibody Revenue Growth Rate (US$ Million), 2021–2032
 Figure 39. Australia Anti-HMGB1 Antibody Revenue Growth Rate (US$ Million), 2021–2032
 Figure 40. China Taiwan Anti-HMGB1 Antibody Revenue Growth Rate (US$ Million), 2021–2032
 Figure 41. Southeast Asia Anti-HMGB1 Antibody Revenue Growth Rate (US$ Million), 2021–2032
 Figure 42. Latin America Anti-HMGB1 Antibody Sales Market Share by Country (2021–2032)
 Figure 43. Latin America Anti-HMGB1 Antibody Revenue Market Share by Country (2021–2032)
 Figure 44. Mexico Anti-HMGB1 Antibody Revenue Growth Rate (US$ Million), 2021–2032
 Figure 45. Brazil Anti-HMGB1 Antibody Revenue Growth Rate (US$ Million), 2021–2032
 Figure 46. Argentina Anti-HMGB1 Antibody Revenue Growth Rate (US$ Million), 2021–2032
 Figure 47. Colombia Anti-HMGB1 Antibody Revenue Growth Rate (US$ Million), 2021–2032
 Figure 48. Middle East and Africa Anti-HMGB1 Antibody Sales Market Share by Country (2021–2032)
 Figure 49. Middle East and Africa Anti-HMGB1 Antibody Revenue Market Share by Country (2021–2032)
 Figure 50. Turkey Anti-HMGB1 Antibody Revenue Growth Rate (US$ Million), 2021–2032
 Figure 51. Saudi Arabia Anti-HMGB1 Antibody Revenue Growth Rate (US$ Million), 2021–2032
 Figure 52. UAE Anti-HMGB1 Antibody Revenue Growth Rate (US$ Million), 2021–2032
 Figure 53. Global Sales Market Share of Anti-HMGB1 Antibody by Type (2021–2032)
 Figure 54. Global Revenue Market Share of Anti-HMGB1 Antibody by Type (2021–2032)
 Figure 55. Global Anti-HMGB1 Antibody Price (US$/g) by Type (2021–2032)
 Figure 56. Global Sales Market Share of Anti-HMGB1 Antibody by Application (2021–2032)
 Figure 57. Global Revenue Market Share of Anti-HMGB1 Antibody by Application (2021–2032)
 Figure 58. Global Anti-HMGB1 Antibody Price (US$/g) by Application (2021–2032)
 Figure 59. Anti-HMGB1 Antibody Value Chain
 Figure 60. Channels of Distribution (Direct Vs Distribution)
 Figure 61. Bottom-up and Top-down Approaches for This Report
 Figure 62. Data Triangulation
 Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Lukasiewicz Research Network